Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Abstract Background Left ventricular (LV) apical aneurysms in hypertrophic cardiomyopathy (HCM) are a recognized risk marker for adverse cardiovascular events. There is variable practice...

Although obesity is associated with increased phenotypic expression in patients with hypertrophic cardiomyopathy (HC), the effect of body mass index (BMI) on in-hospital mortality...

Heart failure encompasses a heterogeneous set of clinical features that converge on impaired cardiac contractile function1,2 and presents a growing public health concern. Previous...

Mashup Score:21

Spotify

Listen to this episode from Don’t Miss a Beat on Spotify. A first-in-class allosteric and reversible inhibitor selective for cardiac myosin approved based on...

AbstractAims. Genetic testing in relatives of hypertrophic cardiomyopathy (HCM) patients leads to early identification of pathogenic DNA variant carriers...

Media Hub - 2 weeks

Mashup Score:17

IMPORTANT SAFETY INFORMATION WARNING: RISK OF HEART FAILURE CAMZYOS reduces left ventricular ejection fraction (LVEF) and can cause heart failure due to systolic dysfunction....

Background Currently, there is no patient-reported outcome (PRO) instrument specifically designed to evaluate hypertrophic cardiomyopathy (HCM). Objective We present the development and psychometric validation...

Objectives: To identify previously unrecognized genetic variants and clinical variables associated with the ICD-10 (International Classification of Diseases 10)-based diagnosis of hypertrophic cardiomyopathy in...

In this two-part hypertrophic cardiomyopathy video series, Dr Ahmad Masri discusses important cardiomyopathy data that has been presented at the ESC–HFA annual congress 2022...

Hypertrophic cardiomyopathy (HCM) is a common form of inherited cardiomyopathy with a prevalence in the general population reported as 0.2% in different international studies.1...